AXIM® Biotechnologies Issues Update Letter to Shareholders

by NASDAQ Market News May 13, 2020

NASDAQ Market News
Click here to email author

BeyondSpring Granted New U.S. Patent for Plinabulin to Treat Severe Chemotherapy-Induced Neutropenia from Taxane in Cancer Patients

BARDA Provides the Sabin Vaccine Institute with an Additional $20 Million for Further Development of Ebola Sudan and Marburg Vaccines

Ads